{"id":"W2231307019","doi":"10.1200/jco.2006.24.18_suppl.7580","title":"A phase I trial of PS-341 and fludarabine for relapsed and refractory indolent non-Hodgkin’s lymphoma and chronic lymphocytic leukemia","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Fludarabine; Mantle cell lymphoma; Chronic lymphocytic leukemia; Bendamustine; Follicular lymphoma; Internal medicine; Neutropenia; Gastroenterology; Macroglobulinemia; Oncology; Leukopenia; Lymphoma; Toxicity; Surgery; Leukemia; Chemotherapy; Multiple myeloma; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004723805,0.0002552647,0.002306454,0.0002872231,0.00007069117,0.00001922629,0.0001598401,0.0007051959,0.0000254667],"category_scores_gemma":[0.003846684,0.0001911846,0.0003493141,0.000155679,0.0009606591,0.0001540266,0.000140615,0.0005404495,0.000001793048],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.01841635,"about_ca_system_score_gemma":0.05863346,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002761815,"about_ca_topic_score_gemma":0.00008594412,"domain_scores_codex":[0.9950858,0.0003330676,0.003150086,0.0004035398,0.000573393,0.0004541489],"domain_scores_gemma":[0.9918008,0.005053421,0.001794358,0.0003078595,0.0004988662,0.0005446344],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4740569,0.004095093,0.0006084936,0.001083315,0.0008428428,0.001238183,0.0002307059,0.00003270154,0.007958043,0.0002479271,0.008205729,0.5014001],"study_design_scores_gemma":[0.840203,0.1117197,0.004000078,0.0003741408,0.0007082366,0.002109825,0.0000699586,0.01136908,0.001054511,0.0005557137,0.02765032,0.0001853544],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9929577,0.0038754,0.0002290962,0.0007357424,0.0006970928,0.0009862497,0.00001109444,0.000009631712,0.0004980391],"genre_scores_gemma":[0.991172,0.003676751,0.001962613,0.0003180501,0.002426437,0.00002274581,0.000006362824,0.00003900588,0.0003760786],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5012147,"threshold_uncertainty_score":0.9853518,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0743556789712439,"score_gpt":0.4604413004812773,"score_spread":0.3860856215100334,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}